Story perspectives

Psychedelic Therapy Gains Ground Amid Public Support

9/18/2025

Summary

Psychedelics Aid Therapy

Psychedelic-assisted psychotherapy (PAP) shows promise in treating mental health issues, especially for terminally ill patients.
Early studies suggest that combining psychedelics like psilocybin with psychological support may improve mood and emotional processing.
Countries including Canada, Australia, Germany, and the Czech Republic are legalizing psilocybin for serious health conditions.
The European Union has invested over €6.5 million in research on psychedelic therapy for progressive illnesses.
A UK survey reveals 68% public support for legalizing PAP for terminally ill patients.

Summary

Veterans Seek Psychedelic Therapy

Tracy Pennycuick plans to introduce a bill to expand Pennsylvania's Right-to-Try Act, allowing veterans access to MDMA and psilocybin therapy for PTSD.
Rep. Mike Schlossberg mentioned that some Democrats faced election losses due to their support for these therapies.
Marine Corps veteran Ryan Gardill advocated for psilocybin therapy, stressing the importance of destigmatizing mental health.
Psilocybin has FDA breakthrough therapy designations for treatment-resistant depression.
Bipartisan support exists for legalizing psilocybin treatments in Pennsylvania, contingent on FDA approval.

History

Historical Context

The Controlled Substances Act of 1970 classified psychedelics like psilocybin as Schedule I drugs, hindering research. However, recent studies in Canada, Australia, and Germany, backed by over €6.5 million from the EU, indicate a shift towards recognizing psychedelics for mental health treatment. A UK survey shows 68% public support for legalizing psychedelic-assisted therapy, highlighting a potential transformation in mental health care approaches.

1 of 3

Psychedelics Aid Therapy

Psychedelic-assisted psychotherapy (PAP) shows promise in treating mental health issues, especially for terminally ill patients.
Early studies suggest that combining psychedelics like psilocybin with psychological support may improve mood and emotional processing.
Countries including Canada, Australia, Germany, and the Czech Republic are legalizing psilocybin for serious health conditions.
The European Union has invested over €6.5 million in research on psychedelic therapy for progressive illnesses.
A UK survey reveals 68% public support for legalizing PAP for terminally ill patients.

1 / 3